Nalaganje...
The clinical development of histone deacetylase inhibitors as targeted anticancer drugs
IMPORTANCE OF THE FIELD: Histone deacetylase (HDAC) inhibitors are being developed as a new, targeted class of anticancer drugs. AREA COVERED IN THIS REVIEW: This review focuses on the mechanisms of action of the HDAC inhibitors, which selectively induce cancer cell death. WHAT THE READER WILL GAIN:...
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2010
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4077324/ https://ncbi.nlm.nih.gov/pubmed/20687783 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/13543784.2010.510514 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|